Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Jan 21;17(1):e0263037. doi: 10.1371/journal.pone.0263037

Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3

The PLOS ONE Editors
PMCID: PMC8782327  PMID: 35061812

After this article was published, similarities were noted between this article and submissions by other research groups which call into question the validity and provenance of the reported results and the adherence of this article to the PLOS Authorship policy. The authors provided data files to support the article’s results, but the comments and files received did not resolve the concerns.

In discussing this matter, the corresponding author requested the article’s retraction.

In light of the above issues, the PLOS ONE Editors retract this article [1].

JC agreed with retraction. TT, QY, CZ, and XL did not respond or could not be reached.

Reference

  • 1.Tian T, Yang Q, Zhang C, Li X, Cheng J (2021) MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3. PLoS ONE 16(5): e0249375. 10.1371/journal.pone.0249375 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES